肾移植术后吃万赛维预防感染吗

Is there anything I should eat to prevent infection after kidney transplantation? Since each patient's condition and personal constitution are different, taking Vancevir may not prevent infection after kidney transplantation. This is determined by the patient's condition and constitution. Patients should use it according to the doctor's diagnosis and treatment recommendations, and should not blindly take this drug for treatment without authorization.

Vancevir (valganciclovir hydrochloride tablets), developed by the Swiss company Roche, is an oral anti-cytomegalovirus infection drug. It is also the prodrug of ganciclovir. Valganciclovir Hydrochloride Tablets is an active ganciclovir valine ester. After oral administration, it can be rapidly hydrolyzed into ganciclovir by phosphatase in intestinal and liver cells. Its antiviral spectrum and mechanism of action are similar to ganciclovir, but the bioavailability of Valganciclovir Hydrochloride Tablets is significantly higher than that of ganciclovir. Its oral absorption bioavailability is 62.4 %, which is 10 times that of ganciclovir, but the toxicity is greatly reduced.

In May 2001, the US FDA approved the marketing of Valganciclovir Hydrochloride Tablets for clinical use in the treatment of acute retinitis caused by CMV infection in patients with acquired immunodeficiency syndrome.

In May 2003, its indications were expanded to include Valganciclovir Hydrochloride Tablets for the prevention and treatment of secondary CMV infection in organ transplant recipients.

On August 11, 2010, Genentech, a member of the Roche Group, announced that the U.S. Food and Drug Administration (FDA) approved Valganciclovir Hydrochloride Tablets for the treatment of adult kidney transplant patients at high risk of cytomegalovirus (CMV) disease.

According to the results of multiple clinical trials, the therapeutic effect of (valganciclovir hydrochloride tablets) is very significant. However, patients cannot blindly take this drug for treatment. Taking Valganciclovir Hydrochloride Tablets for treatment will also produce certain side effects or adverse reactions, including: diarrhea/nausea/vomiting/abdominal pain/neutropenia/anemia/thrombocytopenia/myelosuppression fever/headache/insomnia/peripheral nerve disorders/paresthesia/epilepsy/psychiasis/hallucinations/retinal detachment/decreased renal function, etc. Before receiving treatment with Valganciclovir Hydrochloride Tablets, patients should go to the hospital for a detailed examination and strictly follow the doctor's diagnosis and treatment recommendations.

Recommended related hot articles: /newsDetail/73995.html